ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

CEO

Funcionários

País

Estados Unidos

ISIN

US04522R1014

WKN

000A3D7BB

Listagens

7A9.MU

0 Comments

Compartilhe suas ideias

FAQ

Qual é o símbolo da ação da ASLAN Pharmaceuticals?▼

Dependendo da bolsa, o símbolo da ação pode variar. Por exemplo, na bolsa Boerse Muenchen, as ações da ASLAN Pharmaceuticals são negociadas sob o símbolo 7A9.MU.

Quantos funcionários a ASLAN Pharmaceuticals tem?▼

Em setembro 05, 2026, a empresa tem 35 funcionários.

Em que setor está localizada a ASLAN Pharmaceuticals?▼

ASLAN Pharmaceuticals atua no setor de Tecnologia.

Quando a ASLAN Pharmaceuticals concluiu o desdobro de ações?▼

ASLAN Pharmaceuticals não teve nenhum desdobro recente.

Onde fica a sede da ASLAN Pharmaceuticals?▼

A sede da ASLAN Pharmaceuticals fica em 190 Elgin Avenue, Estados Unidos.